260 related articles for article (PubMed ID: 17785321)
21. Screening tests for antinuclear antibodies (ANA): selective use of central nuclear antigens as a rational basis for screening by ELISA.
Olaussen E; Rekvig OP
J Autoimmun; 1999 Aug; 13(1):95-102. PubMed ID: 10441173
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies.
Shovman O; Gilburd B; Barzilai O; Shinar E; Larida B; Zandman-Goddard G; Binder SR; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1050():380-8. PubMed ID: 16014555
[TBL] [Abstract][Full Text] [Related]
23. [The clinical immunology laboratory in diagnosis and monitoring of systemic lupus erythematosus and connective tissue diseases].
Sinico RA; Radice A
G Ital Nefrol; 2005; 22 Suppl 33():S21-6. PubMed ID: 16419001
[TBL] [Abstract][Full Text] [Related]
24. [Antinuclear antibodies, patterns and characteristics obtained by immunofluorescence. The importance of the IgA, IgM and IgG isotypes].
Arcavi M; Dadone J
Medicina (B Aires); 2009; 69(5):502-6. PubMed ID: 19897433
[TBL] [Abstract][Full Text] [Related]
25. Antinuclear antibodies by indirect immunofluorescence : optimum screening dilution for diagnosis of systemic lupus erythematosus.
Ghosh P; Dwivedi S; Naik S; Agarwal V; Verma A; Aggarwal A; Misra R
Indian J Med Res; 2007 Jul; 126(1):34-8. PubMed ID: 17890821
[TBL] [Abstract][Full Text] [Related]
26. [A comparative study of the ELISA and IF methods for antinuclear antibody test].
Shiba N; Note R; Hayashi S; Ozawa T; Niiya K; Sakuragawa N
Rinsho Byori; 1997 Feb; 45(2):175-8. PubMed ID: 9121002
[TBL] [Abstract][Full Text] [Related]
27. Clinical utility of ANA measured by ELISA compared with ANA measured by immunofluorescence.
Maguire GA; Ginawi A; Lee J; Lim AY; Wood G; Houghton S; Kumararatne DS; Gaston HJ
Rheumatology (Oxford); 2009 Aug; 48(8):1013-4. PubMed ID: 19491301
[No Abstract] [Full Text] [Related]
28. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.
Suarez-Almazor ME; Gonzalez-Lopez L; Gamez-Nava JI; Belseck E; Kendall CJ; Davis P
J Rheumatol; 1998 Oct; 25(10):1980-5. PubMed ID: 9779854
[TBL] [Abstract][Full Text] [Related]
29. Automated antinuclear immunofluorescence antibody analysis is a reliable approach in routine clinical laboratories.
Zheng B; Li E; Zhu H; Lu J; Shi X; Zhang J; Li M
Clin Chem Lab Med; 2017 Oct; 55(12):1922-1930. PubMed ID: 28467309
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of an Automated Screening Assay, Compared to Indirect Immunofluorescence, an Extractable Nuclear Antigen Assay, and a Line Immunoassay in a Large Cohort of Asian Patients with Antinuclear Antibody-Associated Rheumatoid Diseases: A Multicenter Retrospective Study.
Jeong S; Hwang H; Roh J; Shim JE; Kim J; Kim GT; Tag HS; Kim HS
J Immunol Res; 2018; 2018():9094217. PubMed ID: 29854849
[TBL] [Abstract][Full Text] [Related]
31. Screening for connective tissue disease-associated antibodies by automated immunoassay.
Willems P; De Langhe E; Claessens J; Westhovens R; Van Hoeyveld E; Poesen K; Vanderschueren S; Blockmans D; Bossuyt X
Clin Chem Lab Med; 2018 May; 56(6):909-918. PubMed ID: 29306915
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic significance of antinuclear antibodies].
Swaak AJ
Ned Tijdschr Geneeskd; 2000 Mar; 144(13):585-9. PubMed ID: 10761543
[TBL] [Abstract][Full Text] [Related]
33. [Newer approach of screening test for antinuclear antibodies: an enzyme-linked immunosorbent assay detecting antinuclear antibodies characteristic of connective tissue diseases].
Asanuma H; Miyake J; Miyawaki S
Nihon Rinsho Meneki Gakkai Kaishi; 1997 Oct; 20(5):417-27. PubMed ID: 9391305
[TBL] [Abstract][Full Text] [Related]
34. Can an ELISA replace immunofluorescence for the detection of anti-nuclear antibodies?--The routine use of anti-nuclear antibody screening ELISAs.
Sinclair D; Saas M; Williams D; Hart M; Goswami R
Clin Lab; 2007; 53(3-4):183-91. PubMed ID: 17447656
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of enzyme-linked immunosorbent assay for antinuclear antibodies].
Nakabayashi T; Kumagai T; Sakagami S; Furihata K; Katuyama T
Rinsho Byori; 1998 Sep; 46(9):942-7. PubMed ID: 9800481
[TBL] [Abstract][Full Text] [Related]
36. Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis.
Op De Beéck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Autoimmun Rev; 2012 Dec; 12(2):137-43. PubMed ID: 22387973
[TBL] [Abstract][Full Text] [Related]
37. Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera.
Copple SS; Martins TB; Masterson C; Joly E; Hill HR
Ann N Y Acad Sci; 2007 Aug; 1109():464-72. PubMed ID: 17785335
[TBL] [Abstract][Full Text] [Related]
38. Indirect immunofluorescent assay for antinuclear antibodies on McCoy-Plovdiv serum-free cell line substrate.
Zagorov MY; Draganov MM; Alimanska SA; Staykova ND; Stefanov RS; Trayancheva M; Kuzmanova SI; Murdjeva MA
Comp Immunol Microbiol Infect Dis; 2007 May; 30(3):153-62. PubMed ID: 17241662
[TBL] [Abstract][Full Text] [Related]
39. Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis.
Szmyrka-Kaczmarek M; Pokryszko-Dragan A; Pawlik B; Gruszka E; Korman L; Podemski R; Wiland P; Szechinski J
Lupus; 2012 Apr; 21(4):412-20. PubMed ID: 22074845
[TBL] [Abstract][Full Text] [Related]
40. Measurement of antinuclear antibodies by multiplex immunoassay: a prospective, multicenter clinical evaluation.
Moder KG; Wener MH; Weisman MH; Ishimori ML; Wallace DJ; Buckeridge DL; Homburger HA
J Rheumatol; 2007 May; 34(5):978-86. PubMed ID: 17407218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
